Alpine Immune Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALPN and other ETFs, options, and stocks.

About ALPN

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies.

CEO

Mitchell H. Gold

CEOMitchell H. Gold

Employees

142

Employees142

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2007

Founded2007

Employees

142

Employees142

ALPN Key Statistics

Market cap

4.24B

Market cap4.24B

Price-Earnings ratio

-93.34

Price-Earnings ratio-93.34

Dividend yield

—

Dividend yield—

Average volume

2.19M

Average volume2.19M

High today

$64.65

High today$64.65

Low today

$64.33

Low today$64.33

Open price

$64.65

Open price$64.65

Volume

1.92M

Volume1.92M

52 Week high

$64.72

52 Week high$64.72

52 Week low

$6.71

52 Week low$6.71

ALPN News

Yahoo Finance 1d

Earnings Preview: Alpine Immune Sciences, Inc. Q1 Earnings Expected to Decline - Yahoo Finance

The market expects Alpine Immune Sciences, Inc. (ALPN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter...

Analyst ratings

88%

of 8 ratings

Buy

12.5%

Hold

87.5%

Sell